Associations between AAA-related 'events' and self-reported or measured disease risk factors were analyzed in 161,808 women [1]. Participants were 50-79 years of age at study entry with a life expectancy of at least 3 years. Baseline variables collected included a self-reported historical diagnosis of abdominal or thoracic aortic aneurysm disease. Biomorphic data, including height, weight, waist circumference and blood pressure, were obtained via measurement. Health outcomes were recorded following enrolment. Mean study follow-up was 7.8 years. For the purposes of this ana lysis, study end point was an aneurysm-related death or other event recorded following hospitalization and performance of a diagnostic or interventional procedure for AAA disease. Scheduled standardized questionnaires were administered at regular intervals in order to update study-related health outcomes. Accuracy of AAA-related event reporting was confi rmed by medical record review.
future science group PRIORITY PAPER EVALUATION -Dua & Dalman event. Only 18 women who experienced events reported a prior history at enrolment, resulting in a prevalence of 0.3% (467 out of 161,808) in this population. Multivariate ana lysis (odds ratio [OR] , 95% confi dence interval [CI] ) was performed to analyze AAA associations with age (OR: 1.77 per 10 years; 95% CI: 1.37-2.29), history of cigarette smoking (OR: 8.73; 95% CI: 5.04-15.12) and previous diagnosis of aortic aneurysm (OR: 9.00; 95% . Positive associations were also identifi ed for height, hypertension, coronary artery disease, peripheral artery disease and cholesterol-lowering treatment. Negative associations with AAA events were observed with diabetes (OR: 0.29; 95% CI: 0.13-0.68), and postmenopausal hormone therapy use at enrolment (OR: 0.48; 95% CI: 0.31-0.73) or for more than 5 years (OR: 0.52; 95% CI: 0.34-0.78).
Signifi cance of results
The study provides compelling evidence that the strong AAA-related associations previously identifi ed and validated in mainly male cohorts (positive: age and smoking; negative: diabetes) also apply to women. Although few novel associations are identifi ed, the power provided by the size of this population validates the significance of associations suggested in earlier reports [2, 12, 13] . A signifi cant limitation of this study is the reliance on self-reported historical data at baseline assessment. Multiple previous population screening studies, while examining fewer women, have consistently suggested higher disease prevalence, and the lack of objective confi rmation or screening for AAA disease in this study renders it prone to detection and spectrum bias [14] . Previous population-based studies place the true prevalence of AAA disease at up to 2% of women 60 years of age and older. Unfortunately, the true prevalence of known risks such as cigarette smoking and peripheral arterial disease is also uncertain in the absence of confi rmatory diagnostic testing at baseline.
Advanced age is a consistent covariate with AAA-related events [3, 13, 15] . Age plays a special role in gender-related risk in that women presenting with ruptured aneurysms are on average 5 years older than men, but age alone cannot explain all aspects of the outcome disparities between the sexes [9, 16] . Smoking remains the other dominant risk factor regardless of gender. Overall, AAA has the closest association of any disease to cigarette smoking aside from lung cancer, and the relative risk of AAA in individuals who have ever smoked is 2.5-times greater than the relative risk of coronary artery disease [17] . In this study, current female smokers were subject to a fourfold greater risk of AAA events compared with nonsmokers. Smoking may directly augment aortic mural proteolysis among many other potential mechanisms considered in aneurysm pathogenesis [17] . Smoking is a key modifiable risk factor for prevention of AAA as well as potentially reducing the rate of disease progression [18] , and emphasis on smoking cessation in women should be a public health priority.
The negative association between AAA and diabetes, while seemingly paradoxical, was originally recognized in Lederle's US Department of Veterans Affairs Aneurysm Detection and Management trial and has since been confi rmed in several different large population studies on multiple continents [10, [19] [20] [21] [22] [23] . Diabetes may augment matrix volume owing to a combination of increased synthesis and reduced degradation [24, 25] , processes that may prove singularly effective in limiting aneurysm progression while simultaneously exacerbating arterial occlusive disease. There is still no defi nitive explanation of the mechanism for this negative association and, therefore, this may be less useful for improving the management of AAA than other novel parameters.
This study is the fi rst to consider potential associations between postmenopausal hormone therapy and AAA events. Estrogen has long been considered a cardiovascular (CV) protective agent, although this designation is not without controversy [26] . In this study, postmenopausal hormone supplementation therapy at enrolment provided relative protection against subsequent AAA-related events. While reassuring for women already on therapy, the results for postmenopausal women overall were signifi cantly more nuanced. In the estrogen alone arm of the WHI, women randomized to hormone therapy at study entry suffered signifi cantly more AAA events than controls. Event rates declined slightly with the addition of progesterone but did not differ between therapy and control groups [27, 28] .
Data derived from biologically valid AAA rodent models support the hypothesis that sex hormones may infl uence AAA pathophysiology. Chronic angiotensin II (Ang-II) administration in apolipoprotein E-defi cient mice causes disproportionately more AAAs in male as compared with female mice. Pretreatment of males with estradiol prior to Ang-II administration attenuates AAA formation and downregulates proinfl ammatory gene expression [29] . While oophorectomy does not infl uence AAA formation in female mice, future science group Abdominal aortic aneurysm risk factors in postmenopausal women -PRIORITY PAPER EVALUATION orchiectomy in males reduces AAA incidence to that observed in ovary-intact females, suggesting that the balance of androgen/estrogen production may also mediate disease progression [30] . In a complementary experimental AAA model (porcine pancreatic elastase infusion into the isolated infrarenal aortic segment), females are relatively resistant to aneurysmal degradation following elastase infusion, with reduced infl ammation and proteolytic matrix metalloproteinase activity. This resistance is lost when female aortae are transplanted into male recipients prior to infusion [31] . Interestingly, the estrogenic effects of estrogen-receptor activation may not fully explain this benefi t; treatment with tamoxifen, a selective estrogen receptor modulator, is also effective in reducing aneurysmal dilatation, reactive oxygen species (ROS) production and neutrophil infi ltration following elastase infusion in male rats [32] .
Other gender and age-related distinctions potentially relevant to A A A pathogenesis include the role of total body iron stores on systemic infl ammation and the progression of vascular disease. Iron accumulation has been implicated as an independent CV disease factor (although not for AAA disease specifi cally) through increased iron-catalyzed oxidative stress [33] . Total body iron stores as refl ected by serum ferritin levels are signifi cantly reduced in premenopausal women compared with agematched men on western diets but rise rapidly following menopause since no other biologic mechanism exists to reduce iron stores in excess of physiologic requirements [34, 35] . Serum ferritin increases steadily in men from childhood onwards, so that by the age of 45 years levels may be fourfold higher than in women. This increase coincides neatly with observed CV disease risk differentials between men and women by the fi fth decade of life. Although not specifically linked to aneurysms as opposed to other CV disease end points, the iron hypothesis has plausible relevance in that increased ROS generating enzyme activity, increased superoxide radical production and morphologic evidence of oxidative tissue injury are prominent features of human AAA disease [36] . Although differential iron-derived ROS production and oxidative stress may explain the excess prevalence of AAA disease in men, its role in mediating the differential morbidity and inferior treatment outcomes in women is less immediately apparent.
Gender-specifi c pathophysiologic mechanisms may also be mediated by obesity and male/female differences in truncal adipose distribution.
Measures of obesity (waist circumference and waist-to-hip ratio) are independently and positively associated with AAA risk. Obesity may augment AAA infl ammation and progression via adipose cell production of proinfl ammatory adipokines [37] . Male pattern obesity is characterized by truncal and visceral fat accumulation. This type of central adipose deposition has been independently related to insulin resistance and CV risk [38, 39] . Obesity also impairs testosterone production and presumably testosterone-driven infl uences on immunocompetence, maintenance of muscle mass and metabolic equilibrium. Recent population-based studies have suggested that testosterone levels may be negatively associated with AAA risk [40] , a fi nding somewhat at odds with prior experimental data. Femalepattern adiposity shifts towards male-pattern abdominal and visceral deposition in response to increased androgen:estrogen ratios associated with menopause [38] , providing another potential explanation for the older age of AAA onset in women as compared with men.
Physical fi tness and regular exercise may also influence AAA risk. Exercise has long been recognized to reduce all-cause mortality and vascular-related complications in patients with CV disease [41] . Long-term physiologic effects of exercise training serve to decrease heart rate and systolic blood pressure at matched workloads, and increase work capacity and oxygen uptake with a faster return to resting hemo dynamic conditions. Resistive aortic hemodynamics, such as those found in the infrarenal aorta under sedentary conditions, may promote aortic infl ammation, ROS production and AAA risk [42] . The antioxidative infl uences of increased antegrade fl ow, as demonstrated in the aorta following lower extremity exercise, may reduce aortic infl ammation, maintain vascular cell populations and attenuate AAA progression [43] . Exercise reduces systemic markers of infl ammation potentially r elevant to AAA disease (including serum a dipokine levels) and may attenuate progression of early disease [44] [45] [46] . A large-scale clinical trial is underway in the USA to test the effectiveness of supervised exercise training on AAA progression.
Future perspective
A greater understanding of gender-specifi c issues in AAA disease is needed in order to improve the effectiveness of public health awareness, screening programs and treatment outcomes in women. Recognized high-risk subgroups include smokers, those with relevant family histories or concomitant coronary or cerebral vascular future science group PRIORITY PAPER EVALUATION -Dua & Dalman disease or combinations of all three [13, 15] . The addition of three such risk factors and a positive family history in the appropriate age group increases the yield in screening programs from 0.7 to 6.8% [15] . Similarly, redoubled efforts to understand the mechanism(s) responsible for differential outcomes following treatment will be necessary in order to reduce current discrepancies in treatment outcomes and survival for women with advanced disease.
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Executive summary
Abdominal aortic aneurysm (AAA) is a common, asymptomatic and frequently lethal disease of older women as well as men. No • validated treatment guidelines exist for women as a distinct patient subset.
Clear gender differences exist in the epidemiology of AAA disease; although prevalence is higher in men, treatment outcomes are • worse in women and the risk of rupture and sudden death is remarkably disproportionate in women.
Previous association studies have been insuffi ciently powered to consider gender as a distinct variable. This study suggests that similar • risk factor associations exist between sexes and therefore may not be suffi cient to explain observed differences in mortality and treatment outcome.
Better understanding of gender-specifi c issues in AAA pathophysiology and treatment protocols will be necessary to improve outcome • overall for women with this life threatening illness.
